Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,837 | -39,225 | -27,631 | -15,656 | -7,162 |
| Depreciation Amortization | -112 | 1,103 | 1,230 | 1,043 | 435 |
| Accounts payable and accrued liabilities | -2,257 | 2,515 | 1,894 | 5,588 | -611 |
| Other Working Capital | -5,547 | -1,263 | -1,318 | -877 | -2,789 |
| Other Operating Activity | 3,524 | 2,745 | 2,341 | -2,640 | 2,185 |
| Operating Cash Flow | $-12,229 | $-34,125 | $-23,484 | $-12,542 | $-7,942 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,269 | -151,164 | -104,572 | -105,779 | N/A |
| PPE Investments | N/A | -36 | 18 | 45 | -193 |
| Investing Cash Flow | $4,269 | $-151,200 | $-104,554 | $-105,734 | $-193 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 41 | 76,252 | 5 | N/A | N/A |
| Common Stock Repurchased | N/A | -495 | N/A | N/A | N/A |
| Financing Cash Flow | $41 | $75,757 | $5 | $N/A | $N/A |
| Beginning Cash Position | 34,946 | 144,514 | 144,514 | 144,514 | 144,514 |
| End Cash Position | 27,027 | 34,946 | 16,481 | 26,238 | 136,379 |
| Net Cash Flow | $-7,919 | $-109,568 | $-128,033 | $-118,276 | $-8,135 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,229 | -34,125 | -23,484 | -12,542 | -7,942 |
| Capital Expenditure | N/A | -212 | -158 | -131 | -194 |
| Free Cash Flow | -12,229 | -34,337 | -23,642 | -12,673 | -8,136 |